Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases

NCT07448298 is registered in ClinicalTrials.gov with Beijing Boren Hospital as lead sponsor.

NCT NCT07448298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases
Lead sponsor
Beijing Boren Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 9, 2026
Completion date
February 28, 2029
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory autoimmune diseases